Home » Authors » Trista Morrison

Articles by Trista Morrison

Enobia Gets $38M In Series B For Enzyme Replacement Trials

Sep. 12, 2007

By Trista Morrison

Enobia Gets $38M In Series B For Enzyme Replacement Trials

Sep. 12, 2007

By Trista Morrison

Alnylam And Isis Launch JV To Focus On MicroRNA

Sep. 10, 2007

By Trista Morrison

Alnylam And Isis Launch JV To Focus On MicroRNA

Sep. 10, 2007

By Trista Morrison

NewCo News: Mithridion Uses Neuroprotective Pathway To Target Alzheimer's

Sep. 6, 2007

By Trista Morrison

Hyperion Gets $40M Series B For Urea Cycle Disorders

Sep. 6, 2007

By Trista Morrison

Hyperion Gets $40M Series B For Urea Cycle Disorders

Sep. 6, 2007

By Trista Morrison

NewCo News: Mithridion Uses Neuroprotective Pathway To Target Alzheimer's

Sep. 6, 2007

By Trista Morrison

Anacor Seeks $57.5M In IPO For Topical Boron-Based Pipeline

Sep. 5, 2007

By Trista Morrison

Anacor Seeks $57.5M In IPO For Topical Boron-Based Pipeline

Sep. 5, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...